Shanghai No.1 Pharmacy Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	333.18	322.59	436.42	400.03	504.93	262.28
Short-Term Investments	21.6	98.04	85.62	66.29	40	-
Trading Asset Securities	10.03	1.03	15.38	30.15	220.29	-
Cash & Short-Term Investments	364.81	421.67	537.41	496.47	765.22	262.28
Cash Growth	-35.18%	-21.54%	8.25%	-35.12%	191.75%	-48.51%
Accounts Receivable	204.04	189.88	190.15	247.57	238	133.56
Other Receivables	84.88	46.97	30.4	23.31	27.1	31.32
Receivables	288.93	236.85	220.55	270.88	265.1	164.87
Inventory	366.14	354.94	336.32	332.23	334.75	214.5
Prepaid Expenses	-	7.15	9.39	3.52	0.78	0.44
Other Current Assets	21.86	36.42	23.33	14.13	31.29	20.59
Total Current Assets	1,042	1,057	1,127	1,117	1,397	662.69
Property, Plant & Equipment	243.45	253.56	260.88	215.36	181.09	167.98
Long-Term Investments	356.4	358.86	342.74	322.45	252.47	184.14
Other Intangible Assets	35.86	36.46	38.93	41.67	43.83	46.33
Long-Term Deferred Tax Assets	24	26.76	24.35	26.39	35.99	12.07
Long-Term Deferred Charges	23.75	24.57	20.58	16.28	14.43	9.28
Other Long-Term Assets	265.81	264.09	165.58	123.78	114.15	251.97
Total Assets	1,991	2,021	1,980	1,863	2,039	1,334
Accounts Payable	470.03	454.1	384.14	398.59	363.69	314.8
Accrued Expenses	1.93	24.35	26.51	27.09	32.57	15.02
Short-Term Debt	-	49.9	95.58	101.05	320.28	-
Current Portion of Leases	64.34	63.48	63.98	58.34	49.05	38.94
Current Income Taxes Payable	2.4	1.26	0.9	10.27	37.33	5.93
Current Unearned Revenue	9.41	3.55	5.36	5.71	25.53	2.71
Other Current Liabilities	67.12	69.85	71.68	75.74	97.91	66.64
Total Current Liabilities	615.22	666.49	648.15	676.79	926.37	444.04
Long-Term Leases	108.95	107.82	115.56	107.24	88.33	63.08
Long-Term Unearned Revenue	11.38	11.5	11.97	12.44	11.3	11.68
Pension & Post-Retirement Benefits	2.44	2.39	2.5	2.42	-	-
Long-Term Deferred Tax Liabilities	61.42	62.25	57.48	55.83	54.34	37.34
Other Long-Term Liabilities	-	-	-	-	0.07	0.4
Total Liabilities	799.41	850.46	835.66	854.72	1,080	556.54
Common Stock	223.09	223.09	223.09	223.09	223.09	223.09
Additional Paid-In Capital	65.53	65.53	65.53	65.19	65.19	65.19
Retained Earnings	711.91	688.65	679.98	544.95	499.18	371.24
Comprehensive Income & Other	181.1	184.02	167.01	168.22	164.22	111.4
Total Common Equity	1,182	1,161	1,136	1,001	951.67	770.92
Minority Interest	9.97	9.58	8.79	7.01	7.01	7.01
Shareholders' Equity	1,192	1,171	1,144	1,008	958.68	777.92
Total Liabilities & Equity	1,991	2,021	1,980	1,863	2,039	1,334
Total Debt	173.29	221.21	275.12	266.63	457.67	102.03
Net Cash (Debt)	191.52	200.46	262.29	229.83	307.55	160.26
Net Cash Growth	-42.87%	-23.57%	14.12%	-25.27%	91.91%	-51.34%
Net Cash Per Share	0.86	0.90	1.17	1.03	1.37	0.71
Filing Date Shares Outstanding	223.09	223.09	223.09	223.09	223.09	223.09
Total Common Shares Outstanding	223.09	223.09	223.09	223.09	223.09	223.09
Working Capital	426.52	390.53	478.85	440.44	470.77	218.65
Book Value Per Share	5.30	5.21	5.09	4.49	4.27	3.46
Tangible Book Value	1,146	1,125	1,097	959.77	907.85	724.58
Tangible Book Value Per Share	5.14	5.04	4.92	4.30	4.07	3.25
Buildings	-	101.59	105.19	89.34	94.76	94.76
Machinery	-	27.36	26.96	26.52	26	26.32
Construction In Progress	-	7.78	5.74	1.74	1.43	2.24